Friday, Apr 26, 2024
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Science and Tech
Sport
Business
Rewind
...
NRI
View Point
cartoon
Columns
Education Today
Reviews
Property
Videos
Lifestyle
E-Paper
NRI
View Point
cartoon
Columns
Reviews
Education Today
Property
Videos
Lifestyle
"dr-reddys-laboratories"
Dr Reddy’s Lab seeks emergency use authorisation for Sputnik V
As part of the review process, the drug major will present the safety profile of phase 2 study, and interim data of phase 3 trial, which is expected to be complete by February 21
Dr Reddy’s Laboratories launch generic epilepsy drug in US market
With a CGT designation, the company has a 180-day CGT exclusivity to market this product, he added.
Dr Reddy’s posts Q3 profit of Rs 19.8 crore
Total revenue from operations stood at Rs 4,929.6 crore for the third quarter, up 12.38 per cent year-on-year
Dr Reddy’s gets DCGI nod for phase 3 trial for Sputnik V vaccine
The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India
Belgium forging ties with Hyderabad
Exploring opportunities for mutual investments and trade in the life sciences sector
Dr Reddy’s, RDIF commence clinical trials for Sputnik V vaccine
Trial will be a multicentre, randomised controlled study, which will include safety and immunogenicity
Russian vaccine arrives in India for human clinical trial
The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.
Dr Reddy’s partners with BIRAC for Sputnik V vaccine trials in India
Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres
Dr Reddy’s detects cyber-attack, isolates its data centre services
Says it anticipates all services to be up within 24 hours and do not foresees any major impact on its operations
Dr Reddy’s, RDIF receive approval to conduct clinical trial for Sputnik V vaccine
This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.
Dr Reddy’s joins global initiative to reduce carbon emissions
The company has committed to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 55 per cent by 2030 from a FY2017-18 base year.
«
1
2
3
Latest News
Election Commission censures Telangana minister for making unsubstantiated allegations
49 seconds ago
Ponnam Prabhakar assures of support to weavers, asks them not to take extreme steps
11 mins ago
Tree near Lulu Mall translocated despite high risk during summer
12 mins ago
Hyderabad: Gang rape case solved, two including juvenile held
28 mins ago
Election observer inspects reception and counting centre in Khammam
43 mins ago
BJP has no intention to change the Constitution, says Kishan Reddy
43 mins ago
Inspector lauded for donating liver to mother in Mancherial
51 mins ago
TSNPDCL CMD visits NTPC Ramagundam
55 mins ago